 |
Also known as: Zavesca
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Miglustat.
No reviews have yet been submitted. Be the first to review this drug.
Feb 8, 2012 - Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today four-year follow-up data from patients enrolled in the phase 2...
An article in the early edition (December 12, 2011) of the Proceedings of the National Academy of Sciences USA , reported that Lixte's investigational drug,...
Protalix BioTherapeutics, Inc. announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the...
Protalix BioTherapeutics announced this morning the publication of its pivotal Phase 3 data for taliglucerase alfa for Gaucher Disease in Blood, the Journal...
Data Presented at the 2011 Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM) NYON, Switzerland, Aug. 31, 2011 /PRNewswire/...
Looking for answers? Ask a question or go join the miglustat support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
